Related Experiment Video
Updated: Jul 12, 2026

Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay
Published on: June 25, 2019
[85-years-old patient with paraneoplastic polyneuropathy]
Małgorzata Pieta1, Magdalena Boczarska-Jedynak, Mariusz Byrski
1Katedry i Kliniki Neurologii Wieku Podeszłego, Slaskiej Akademi Medycznej w Katowicach.
Paraneoplastic syndromes (PS) are autoimmune reactions targeting the nervous system, often preceding cancer diagnosis. Early suspicion of PS in unexplained polyneuropathy is crucial for timely diagnosis and treatment.
Area of Science:
- Neurology
- Oncology
- Immunology
Background:
- Paraneoplastic syndromes (PS) arise from autoimmune responses to tumor antigens affecting the nervous system.
- Common neurological manifestations include Lambert-Eaton syndrome, cerebellar degeneration, and polyneuropathies.
- Oat cell lung carcinoma, ovarian, breast cancer, neuroblastoma, thymoma, and lymphoma are frequent associated neoplasms.
Observation:
- A case series identified 6 patients with paraneoplastic polyneuropathy between 2001-2004.
- An 86-year-old male presented with peripheral polyneuropathy and respiratory failure, a paraneoplastic syndrome preceding lung cancer diagnosis by ten months.
- Diagnostic and therapeutic challenges in managing PS were discussed.
Findings:
- Paraneoplastic polyneuropathy can manifest significantly before the primary tumor is detected.
- Autoimmune reactions against shared neural and tumor antigens drive PS pathogenesis.
- Prompt recognition of PS is vital for patient management.
Implications:
- This case highlights the importance of considering PS in undiagnosed polyneuropathy, especially with respiratory failure.
- Early detection of paraneoplastic syndromes can lead to earlier cancer diagnosis and intervention.
- Further research into diagnostic and therapeutic strategies for PS is warranted.
Related Concept Videos
Diabetic Neuropathy
Pharmacodynamics in Geriatric Patients: Effects of Age
Neural Regulation
Parkinson Disease ll: Pathophysiology
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease: Overview